Full-Time

GCI CMI & Innovation Team Lead

Vaccine

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

East Side, PA, USA

Category
Lab & Research
Life Sciences
Medical Research
Required Skills
Inventory Management
Requirements
  • Expertise in T-cell and B-cell proliferation assays, high-dimensional flow cytometry, and intracellular cytokine staining.
  • Experience managing teams of 10+ individuals.
  • Experience with quality systems and processes in a regulated environment.
  • Expertise with LIMS systems, reagent characterization and qualification, laboratory equipment and supplies.
  • Ability to interact effectively with people from diverse cultural backgrounds and skill sets to achieve scientific and operational excellence.
  • Strong commitment to scientific excellence and innovation.
  • Excellent interpersonal skills to ensure target completion and foster workplace respect.
  • Leadership that promotes cross-group collaboration to achieve Sanofi R&D goals, and developing leadership skills in direct reports.
  • Record of innovation as evidenced by a strong publication record, inventorship on patents/filings and presentations at major conferences.
  • Proven experience in management of personnel, budget, and projects.
  • BS degree in life sciences with 15+ years of relevant experience, MS or Ph.D. in immunology, microbiology, virology or biochemistry (MS requires 12 + years, Ph.D 8+ years of relevant experience).
  • 5+ years experience working in a regulated laboratory as a research scientist or laboratory manager preferably in pharma R&D.
  • Experience in the development of new bioanalytical characterization methods for vaccines.
  • Familiar with a broad range of functional bioanalytical and LBA instrumentation and techniques.
  • Strong familiarity with immunogenicity assays.
  • Understanding of GXP practices and procedures required.
  • Work experience both in early phase product development and clinical stage.
  • Laboratory management and/or operations experience preferred.
  • Familiarity with clinical or sample databases and inventory management required.
  • Proven leadership and managerial experience in multi-functional and matrixed teams.
  • Familiarity with laboratory testing regulations.
  • Proven leadership, verbal and written communication, organizational and team management skills.
  • Proven ability to develop and implement new procedures/processes.
Responsibilities
  • Lead a large team of Bachelors, Masters, and Ph.D. scientists to develop, validate, and execute novel CMI clinical assays for vaccine clinical endpoints.
  • Optimize existing CMI assays, delivering high-quality results in a GCLP-regulated environment.
  • Oversee GCI automation efforts across different platforms (LBA’s neuts) to enhance the clinical testing environment's innovation and efficiency.
  • Collaborate closely with global project teams and immunology team leads.
  • Drive continuous improvement and advancement of techniques and technologies for novel vaccine candidates at Sanofi Vaccines R&D.
  • Represent the team on project, process, and investigation teams, ensuring appropriate planning, organization, and resource allocation.
  • Interact and liaise within the other platform leads and GI department heads and scientists to ensure end-to-end GI communication is maintained.
  • Serve as function representative and SME at key strategic internal/external meetings, conferences/congresses, and key meetings with CROs and with regulatory authorities.
  • Act transversally (including with global transversal operations, clinical development, global regulatory affairs) to build and optimize novel bioanalytical methods for fast-moving projects to maximize scientific quality and timeliness whilst operating within budget targets.
  • Act as a contributing author to high-quality publications describing assay development and/or the immunogenicity and efficacy of candidate and approved drugs in technical, medical, or scientific journals.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?